Prognostic potential of mid‐treatment nodal response in oropharyngeal squamous cell carcinoma. Issue 1 (21st September 2020)

• Record Type: Journal Article
• Authors: Byun, David J.; Tam, Moses M.; Jacobson, Adam S.; Persky, Mark S.; Tran, Theresa T.; Givi, Babak; DeLacure, Mark D.; Li, Zujun; Harrison, Louis B.; Hu, Kenneth S.
• Is Part Of: Head & neck. Volume 43:Issue 1(2021)
• Page Start: 173
• Page End: 181
• Publication Date: 2020-09-21
• Subjects: chemoradiation -- cone beam CT -- oropharyngeal cancer -- p16 -- radiation therapy; Head -- Diseases -- Periodicals; Neck -- Diseases -- Periodicals; Head -- Periodicals; Neck -- Periodicals; Face -- Periodicals; 617.51059
• DOI: 10.1002/hed.26467
• Languages: English
• ISSNs: 1043-3074

Abstract

Abstract: Background: We examine the prognostic implications of mid‐course nodal response in oropharyngeal cancer (OPX) to radiation therapy. Methods: In 44 patients with node‐positive OPX undergoing concurrent chemoradiation, nodal volumes were measured on cone beam CTs from days 1, 10, 20, and 35. Nodal decrease (ND) was based on percent shrinkage from day 1. Results: At a median follow‐up of 17 months, the 2‐year disease‐free survival (DFS), locoregional control (LRC), distant metastasis‐free survival (DMFS), and overall survival (OS) were 87%, 92%, 89%, and 92%, respectively. Patients with ND ≥43% at D20 had improved LRC (100% vs 78.4%, P = .03) compared to D20 ND <43%. On multivariate analysis, D20 ≥43% was independently prognostic for LRC (HR 1.17, P = .05). Conclusion: Patients with low‐risk oropharynx cancer with ND of ≥43% by treatment day 20 had significantly improved LRC. The prognostic benefit of ND may assist in identifying candidates for treatment de‐escalation.